221 related articles for article (PubMed ID: 32917965)
21. Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
Sung JY; Shin HT; Sohn KA; Shin SY; Park WY; Joung JG
PLoS One; 2019; 14(7):e0219682. PubMed ID: 31310640
[TBL] [Abstract][Full Text] [Related]
22. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
Mroz EA; Rocco JW
Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer.
Zhao W; Zhu B; Hutchinson A; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Wang D; Shi J; Landi MT
J Natl Cancer Inst; 2022 Feb; 114(2):280-289. PubMed ID: 34402912
[TBL] [Abstract][Full Text] [Related]
24. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
25. The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer.
Luo J; Chen C; Liu Z; Wang X
Front Cell Dev Biol; 2022; 10():1045130. PubMed ID: 36684432
[TBL] [Abstract][Full Text] [Related]
26. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
27. Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer.
Sirab N; Drubay D; Maillé P; Popova T; Ngo C; Gentien D; Moktefi A; Soyeux-Porte P; Pelletier R; Reyes C; Henry E; Pouessel D; Vordos D; Lebret T; de Reyniès A; Paoletti X; Radvanyi F; Allory Y
J Pathol; 2022 Jan; 256(1):108-118. PubMed ID: 34611919
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
[TBL] [Abstract][Full Text] [Related]
30. The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer.
Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
J Immunother Cancer; 2019 Apr; 7(1):98. PubMed ID: 30944026
[TBL] [Abstract][Full Text] [Related]
31. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
[TBL] [Abstract][Full Text] [Related]
32. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer.
Kim TM; Jung SH; Baek IP; Lee SH; Choi YJ; Lee JY; Chung YJ; Lee SH
J Pathol; 2014 Aug; 233(4):425-35. PubMed ID: 24870262
[TBL] [Abstract][Full Text] [Related]
33. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.
Wang Y; Xu J; Lan T; Zhou C; Liu P
Cancer Med; 2023 Dec; 12(24):21651-21665. PubMed ID: 37965778
[TBL] [Abstract][Full Text] [Related]
34. A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis.
Jung AC; Job S; Ledrappier S; Macabre C; Abecassis J; de Reyniès A; Wasylyk B
Clin Cancer Res; 2013 Aug; 19(15):4174-84. PubMed ID: 23757353
[TBL] [Abstract][Full Text] [Related]
35. Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.
Zhang J; Yan S; Liu X; Gan L; Wu Z; Gong Y; Huang M; Zhang X; Guo W
Carcinogenesis; 2017 Aug; 38(8):837-846. PubMed ID: 28531253
[TBL] [Abstract][Full Text] [Related]
36. Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.
Planells-Palop V; Hazazi A; Feichtinger J; Jezkova J; Thallinger G; Alsiwiehri NO; Almutairi M; Parry L; Wakeman JA; McFarlane RJ
Mol Cancer; 2017 Apr; 16(1):84. PubMed ID: 28446200
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq.
Zhou R; Liang J; Chen Q; Tian H; Yang C; Liu C
Aging (Albany NY); 2021 Aug; 13(15):19415-19441. PubMed ID: 34339395
[TBL] [Abstract][Full Text] [Related]
38. Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.
Mishra R
Pathol Res Pract; 2024 Jan; 253():154953. PubMed ID: 38039738
[TBL] [Abstract][Full Text] [Related]
39. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
40. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
Stanta G; Bonin S
Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
